Australian clinicians and chemoprevention for women at high familial risk for breast cancer
<p>Abstract</p> <p>Objectives</p> <p>Effective chemoprevention strategies exist for women at high risk for breast cancer, yet uptake is low. Physician recommendation is an important determinant of uptake, but little is known about clinicians' attitudes to chemoprev...
Main Authors: | Keogh Louise A, Hopper John L, Rosenthal Doreen, Phillips Kelly-Anne |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-05-01
|
Series: | Hereditary Cancer in Clinical Practice |
Online Access: | http://www.hccpjournal.com/content/7/1/9 |
Similar Items
-
How do women at increased, but unexplained, familial risk of breast cancer perceive and manage their risk? A qualitative interview study
by: Keogh Louise A, et al.
Published: (2011-09-01) -
Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention.
by: Elad Ziv, et al.
Published: (2017-01-01) -
Validation study of risk prediction models for female relatives of Australian women with breast cancer
by: MacInnis R, et al.
Published: (2012-04-01) -
The Risk of Breast Cancer and the Role of Chemoprevention in Women With Atypical Ductal or Lobular Hyperplasia
by: Mahtab Vasigh, et al.
Published: (2018-06-01) -
Breast cancer chemoprevention
by: Ivana Sestak, et al.
Published: (2011-12-01)